Tokyo court rejects Shire claim against Roche haemophilia drug

Chugai, which is 60 percent Roche-owned and which developed Hemlibra, said it expected no change to its financial prospects due to the ruling. “Tokyo District Court rendered a decision in favour of Chugai’s claim,” Chugai said on its website. “(Shire’s …
( read original story …)


Related Post

BRIEF-Yokohama Reito to take out 15 bln yen hybrid...
views 161
29 * Maturity on March 31, 2077 Source text in Jap...
Japan calls for ’emergency measure’ blocking acces...
views 81
The Cabinet Office’s Intellectual Property Strateg...
Japan to conduct evacuation drill to prepare for N...
views 229
Kyodo news agency reported Friday. The drill will ...
Emirates marks 15th year of operations to Japan
views 114
Emirates offers special Japanese cuisine, includin...
Japan’s deployment of F-35A mired in controv...
views 83
TOKYO -- Japan deployed its first F-35A stealth fi...
How Jack Ma Is Selling Jobs to Trump
views 182
Alibaba went public in the U.S. in 2014, raising $...
N'Dam defeats Murata in split decision
views 186
TOKYO (AP) — WBA middleweight interim champion Has...
U.S., Japan agree to ramp up diplomatic pressure o...
views 127
TOKYO - U.S. and Japanese diplomats agreed Tuesday...
Tokyo 2020 to study golf club's membership po...
views 162
Tokyo 2020 organizers say they will review members...
Japan Finance Minister Aso, U.S. Treasury Secretar...
views 181
TOKYO Japanese Finance Minister Taro Aso and U.S. ...